Trauma-Informed Care for Smoking Cessation for Pregnancy
TRauma-Informed Care in Smoking cEssation for Pregnancy (RISE Pregnancy)
2 other identifiers
interventional
20
1 country
1
Brief Summary
Trauma-informed approaches have been shown to support recovery from other substance use disorders and involve four key elements: (1) Realizing the prevalence of trauma and pathways to recovery, (2) Recognizing symptoms of trauma, (3) Responding by embedding knowledge of trauma into practices and policies and (4) Resisting re-traumatization (the 4Rs). In close partnership with Breathe California and a public safety-net clinic in San Francisco that serves primarily racial and ethnic minoritized (REM) pregnant women, the 4Rs along with the Ask, Advise, Assess, Assist and Arrange (the 5As) evidence-based intervention for tobacco cessation that is delivered by health care professionals and is a US Public Health Services clinical practice guideline for treating tobacco will be used to create and implement a smoking cessation intervention for pregnant women with experiences of trauma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedStudy Start
First participant enrolled
November 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
April 23, 2026
April 1, 2026
8 months
August 11, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of themes (Aim 1)
Themes related to how to improve smoking cessation for pregnant people will be identified through in-depth interviews.
Up to 6 months
Study Arms (1)
Aim 1: Development, Pilot Group
EXPERIMENTALBoth clinician- and patient-participants will participate in a 60-minute in-depth, semi-structured interview conducted either in-person or via secure University of California, San Francisco (UCSF) video-telephone software.
Interventions
Expired CO will be measured using a non-investigational device
Participants will be interviewed via video conference or in person
Participants will receive questionnaires to complete through the course of the study
Eligibility Criteria
You may qualify if:
- Clinician Eligibility Criteria (Aims 1 - 3):
- In Aims 1-3, will be recruiting clinicians working in our clinic sites.
- Nurse practitioner, physician assistant, nurse-midwife, medical doctor, registered nurse, clinical pharmacist, behavioral health professional, social worker, or any other healthcare professional caring for pregnant patient-participants.
- Age ≥ 18 years old.
- Patient-participant Eligibility Criteria (Aim 1):
- In Aim 1, will be recruiting pregnant women (ages 18+) who:
- Currently smoking or report having smoked during a previous pregnancy
- Age ≥18 years old.
- Currently Pregnant.
- Identifies as a cisgender woman, or female at birth.
- Reports having experienced trauma aligned with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) definition for traumatic exposure.
- Proficient in English or Spanish languages.
- Patient-Participant Eligibility Criteria (Aim 2):
- Patient-participants will be recruited to give feedback on our intervention using Evidence-Based Quality Improvement (EBQI) meetings.
- Current or former patient in the participating clinical sites.
- +9 more criteria
You may not qualify if:
- \. Any condition, including active mental health crises or cognitive impairment, that would interfere with the ability to provide informed consent or safely complete the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zuckerberg San Francisco General Hospital
San Francisco, California, 94115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anita Hargrave-Bouagnon, MD, MAS
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2025
First Posted
August 19, 2025
Study Start
November 19, 2025
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
April 23, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share